Amarin Corp Plc (AMRN)

[BioChica]

I think it will change the fundamentals of, how physicians treat the disease. They will focus more on inflammatory markers rather than lipid levels alone. If the Zetia outcomes trial fails this fall, a lot of doctors out there, will be scratching their heads.

IMPROVE-IT
Enrollment: 18141
Study Start Date: October 2005
Estimated Study Completion Date: September 2014